lisi-group.comCrawled Nov 17, 2026
LISI Group designs and manufactures assembly components and fasteners for aerospace, automotive, and medical industries.
LISI Group supplies fasteners and assembly components for aerospace, automotive, and medical industries.
LISI reports a **12.8% increase in third-quarter sales**, driven by strong aeronautics performance that counterbalances a decline in automotive revenue. The company’s consolidated revenue for the first nine months of 2026 reaches **1,416.0 million euros**, an **8.0% year-over-year rise** (10.3% on a constant scope). Growth in aerospace components offsets weaker demand in automotive markets.
LISI Group reports a **12.8% year-over-year revenue increase in Q3 2026**, driven by strong performance in the aerospace sector. Meanwhile, its automotive segment, LISI AUTOMOTIVE, sees a **5.2% decline over nine months**. The company highlights aerospace as a key growth driver amid mixed sectoral results.
LISI reports **1.416 billion euros in consolidated sales** for the first nine months of 2026, alongside EBIT and net profit figures. The company highlights sustained financial performance amid ongoing operations. Quarterly financial updates include key metrics like revenue, profitability, and operational efficiency.
SK Capital Partners acquires LISI Group’s medical division and rebrands it as Precera Medical. The deal follows a prior announcement but omits financial details. The unit operates within the medical technology sector, though specific products or customer focus remain unstated.
SK Capital Partners is in exclusive talks to acquire **Lisi Medical**, the medical division of France-based **LISI Group**. The deal aims to expand SK Capital’s presence in the life sciences **contract development and manufacturing organization (CDMO)** sector. The acquisition is expected to finalize in the second half of 2025.